Lotus Eye Hospital and Institute Limited is an India-based company, which is engaged in the business of healthcare activities. The Company is engaged in the field of ophthalmology (eye) and its related operations. It resolves a range of eye problems, such as refractive, cataract, cornea infections, ocular prosthesis, orbit and oculoplasty, glaucoma, keratoconus, computer vision syndrome, neuro ophthalmology, retinal disease/diabetic eye care, UVEA and ocular inflammation, zyoptix-ultimate, and binocular vision. The Company provides various treatments, suchas ReLEx SMILE, Touchfree Laser, Lasik Eye Surgery, Epi-LASIK, Intralase, Supracor, Robotic Femto Laser Cataract Surgery (LRCS), Phacoemulsification, Paediatric Eye Care and Squint Surgery, and Micro Incision Cataract Surgery (MICS). The Company operates in various locations, such as Sitra, Coimbatore; RS Puram, Coimbatore; Salem; Tirupur; Mettupalayam; Kochi; Mulanthuruthy; Saravanampatty, and Karur.
Lotus Eye Hospital and Institute Ltd FAQs
How to Buy Lotus Eye Hospital and Institute Ltd Share?
To purchase Lotus Eye Hospital and Institute Ltd shares, you can open a Demat & Trading account through a broker or financial institution. Once your account is set up and funded, search for Lotus Eye Hospital and Institute Ltd (ticker symbol: LOTUSEYE) on the trading platform provided by your broker and purchase the shares.
What's Lotus Eye Hospital and Institute Ltd share price today?
The stock price of Lotus Eye Hospital and Institute Ltd as of 07 Oct 2025 is ₹119.89
What is the Market Cap of Lotus Eye Hospital and Institute Ltd?
Market capitalisation represents the total market value of a company's outstanding shares. As of 07 Oct 2025, Lotus Eye Hospital and Institute Ltd (ticker symbol: LOTUSEYE) has a market capitalisation of approximately ₹2,50,00,00,000.00
What is the PE and PB ratio of Lotus Eye Hospital and Institute Ltd?
Lotus Eye Hospital and Institute Ltd Ltd's price-to-book ratio as of 07 Oct 2025 is 4.16, reflecting the market's valuation compared to its asset value. As of 07 Oct 2025, the trailing twelve months P/E (price-to-earnings) ratio is 333.03, indicating the market values the company at around ₹333.03 for every ₹1 of earnings
What is the 52 Week High and Low of Lotus Eye Hospital and Institute Ltd Share?
Lotus Eye Hospital and Institute Ltd Ltd (LOTUSEYE) hit its 52-week high at ₹139.20, and its 52-week low at ₹54.99.